Post-earnings recap
Reported
Wed, Feb 27, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report shows that Teladoc Health continues to struggle with profitability, as indicated by the negative EPS. However, the stock rose by 2.34%, suggesting that investors may be optimistic about the company's long-term growth potential despite the current challenges. Management's focus on technology investments could be a positive sign for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.35 | N/A | -1.72% |
Management expressed concerns about the path to profitability while reaffirming their commitment to innovation. They are focused on long-term growth strategies.
Management highlighted challenges in achieving profitability.
They emphasized ongoing investments in technology and services.
The focus remains on long-term growth despite short-term losses.